US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

107.61

-0.4500-0.42%

Post-market: 107.610.00000.00%19:30 EDT

Volume:294.28K

Turnover:31.62M

Market Cap:1.03B

PE:87.19

High:108.01

Open:107.78

Low:106.86

Close:108.06

52wk High:118.00

52wk Low:90.60

Shares:9.54M

Float Shares:9.54M

Volume Ratio:0.67

T/O Rate:3.09%

Dividend:2.14

Dividend Rate:1.99%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):138.59

Loading ...

Overview Company News Filings

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

FDA approves Welireg and Lenvima combo for ccRCC

Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81

THOMSON REUTERS

FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component

THOMSON REUTERS

Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says

MT Newswires Live

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

Novartis Poised for Sales Growth Acceleration

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal

Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults

Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma

THOMSON REUTERS

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/PPH/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":107.61,"timestamp":1791230400000,"preClose":108.06,"halted":0,"volume":294281,"hourTrading":{"tag":"盘后","latestPrice":107.61,"preClose":107.61,"latestTime":"19:30 EDT","volume":762,"amount":81998.832192,"timestamp":1791243002953,"change":0,"changeRate":0,"amplitude":0.000093},"delay":0,"changeRate":-0.004164353137146056,"floatShares":9538138,"shares":9538138,"eps":1.234146,"marketStatus":"Post-Mkt","change":-0.45,"latestTime":"10-05 19:51:40 EDT","open":107.78,"high":108.005,"low":106.8645,"amount":31615790.83962,"amplitude":0.010554,"askPrice":107.77,"askSize":2501,"bidPrice":107.22,"bidSize":2800,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.06,"sharesOutstanding":11938138,"nav":108.04699,"aum":1014360012.4,"dividendRate":0.019883,"bidAskSpread":0.000353,"preHourTrading":{"tag":"盘前","latestPrice":108.1954,"preClose":108.06,"latestTime":"08:39 EDT","volume":153,"amount":16616.96127,"timestamp":1791203968219,"change":0.1354,"changeRate":0.001253,"amplitude":0.026334},"postHourTrading":{"tag":"盘后","latestPrice":107.61,"preClose":107.61,"latestTime":"19:30 EDT","volume":762,"amount":81998.832192,"timestamp":1791243002953,"change":0,"changeRate":0,"amplitude":0.000093},"volumeRatio":0.667921,"impliedVol":0.2128,"impliedVolPercentile":0.7131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9538138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.667921,"shares":9538138,"dividePrice":2.1396,"high":108.005,"amplitude":0.010554,"preClose":108.06,"low":106.8645,"week52Low":90.6,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":107.61,"committee":0.056404,"eps":1.234146,"divideRate":0.019883,"volume":294281,"delay":0,"ttmEps":1.234146,"open":107.78,"prevYearClose":103.17,"prevWeekClose":108.06,"prevMonthClose":109.47,"prevQuarterClose":109.47,"fiveDayClose":111.48,"twentyDayClose":114.21,"sixtyDayClose":108.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"PPH","amount":0.36,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-06","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-06"},{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"},{"executeDate":"2018-04-02","recordDate":"2018-04-03","paymentDate":"2018-04-06","value":0.3943,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670494824","title":"After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494824","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670494824?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:11","pubTimestamp":1790327460,"startTime":"0","endTime":"0","summary":"Novo Nordisk struck a licensing deal with a Swedish company worth over $1 billion.Just days after a capital-markets day left investors wondering what's next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.The deal announced on Thursday give Novo a global exclusive license to a drug-delivery technology platform from Sweden's Nanexa for certain therapeutic peptide drugs in medical conditions including obesity, type 2 diabetes and other cardiometabolic diseases.Novo is the company behind blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, but investors are concerned that its next-generation products are lacking.Nanexa is eligible to receive upfront consideration and potential milestone payments totaling up to EUR1.17 billion , including EUR615 million in upfront payment and development and regulatory milestones. In addition, the agreement provides for low single-digit royalties on future product sales.The news sent the Swedish company  , wh","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","BK4588","IE00BKVL7J92.USD","NVO","BK4007","NRNVF","PPH","OZEM","BK4585","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOC","THNR","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445217","title":"Novo Nordisk Licenses Nanexa Drug Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445217","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445217?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:46","pubTimestamp":1790322401,"startTime":"0","endTime":"0","summary":"Novo Nordisk  agreed to a global exclusive license with Nanexa to use the latter's PharmaShell drug delivery technology in up to five development programs targeting obesity, type 2 diabetes and other cardiometabolic conditions, Nanexa said Thursday.The companies will develop long-acting injectable formulations with target dosing schedules of once monthly or once quarterly, Nanexa saidThe company said it is eligible for up to 1.17 billion euros  in total payments, including 615 million euros in upfront and development and regulatory milestones.The remaining payments are tied to sales milestones, Nanexa said, adding it will also receive low-single-digit royalties on global net sales of products developed under the agreement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","OZEM","BK4588","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","NVO","BK4007","IE00BZ1G4Q59.USD","NVOX","PPH","BK4599","BK4585","NVOH","LU1093756325.SGD","NVOC","THNR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2670490065","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490065?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:55","pubTimestamp":1790279714,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 36c, or 0.96%, near $38.53. Options volume more than double the daily...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-96-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-96-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","NVOX","OZEM","NVO","BK4585","IE00BKVL7J92.USD","NVOC","PPH","THNR","BK4599","BK4007","NVOH","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490795","title":"FDA approves Welireg and Lenvima combo for ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490795","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:35","pubTimestamp":1790278513,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved Welireg from Merck (MRK) in combination with Lenvima from Eisai (ESAIY) for adults with advanced renal ce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU1057294990.SGD","SG9999002232.USD","MRK","LU1291159041.SGD","BK4559","BMED","SG9999001440.SGD","LU1983299246.USD","LU0208291251.USD","IE00BLSP4239.USD","LU0861579265.USD","LU2361044865.SGD","LU1430594728.SGD","LU2324357040.USD","LU0238689110.USD","LU1989771016.USD","LU1066051811.HKD","LU0965508806.USD","LU0203345920.USD","LU1061106388.HKD","LU0265550359.USD","LU1923622614.USD","BK4534","LU0266013472.USD","LU0985320562.USD","LU0320765646.SGD","LU1571399168.USD","LU2461242641.AUD","LU0980610538.SGD","LU1066053197.SGD","LU0234572021.USD","LU1037948897.HKD","LU2125909247.SGD","LU0689626769.HKD","LU0942090050.USD","LU0823416689.USD","LU2023250504.SGD","LU1929549753.HKD","LU1093756168.USD","LU2106854487.HKD","LU0472753341.HKD","LU0868494708.USD","LU0965509010.AUD","LU0057025933.USD","PAWZ","LU1066051498.USD","BK4516","LU0006306889.USD","FTXH","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0289739343.SGD","LU1585245621.USD","LU2089984988.USD","JDOC","SG9999002224.SGD","LU1989772840.SGD","LU1941712264.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU1974910355.USD","LU0965509101.SGD","LU0130102774.USD","IE00BN8TJ469.HKD","SG9999015358.SGD","SG9999014542.SGD","LU1934455863.HKD","LU0211331839.USD","LU0289739699.SGD","LU2125154935.USD","IYH","LU1093756325.SGD","LU1116320737.USD","LU2125909593.SGD","LU0432979614.USD","HRTS","SG9999014575.USD","LU1201861249.SGD","XLV","LU1989772923.USD","RXL","LU0868494617.USD","LU0162691827.USD","LU1917777945.USD","LU0072461881.USD","SG9999013999.USD","LU0069063385.USD","LU2491049909.HKD","IE00B1BXHZ80.USD","SG9999001176.SGD","LU0058720904.USD","LU0265550946.USD","LU1934455277.USD","IE00BBT3K403.USD","LU2468319806.SGD","LU1941712348.USD","TRUH","LU0477156953.USD","IE0009355771.USD","BK4550","IXJ","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0124676726.USD","SG9999014559.SGD","SG9999014567.USD","SGXZ57979304.SGD","SG9999015341.SGD","LU1069347547.HKD","LU1934455194.USD","BK4588","LU0965509283.SGD","LU1066051225.USD","LU1162221912.USD","ESAIY","LU0289961442.SGD","LU2360032135.SGD","LU1037948541.HKD","SG9999001176.USD","GDOC","LU1699723380.USD","FHLC","LU0859254822.USD","LU1032466523.USD","LU0203347892.USD","LU2357627491.SGD","BK4007","BK4533","LU0122379950.USD","LU2491050071.SGD","LU0130517989.USD","LU1116320901.HKD","LU1023059063.AUD","LU2361044949.HKD","LU2125154778.USD","LU0320765489.SGD","VHT","LU0648001328.SGD","IE00BLSP4452.SGD","IHE","LU2491050154.USD","PPH","LU2433249047.HKD","BK4585","LU0511384066.AUD","LU1035773651.USD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490194","title":"Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490194?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:28","pubTimestamp":1790278130,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G17P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1699723380.USD","LU2361044949.HKD","LU1066051811.HKD","LU2360032135.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0868494708.USD","BK4559","LU1037948897.HKD","LU1032466523.USD","LU2125909593.SGD","SG9999001176.SGD","LU1989772840.SGD","LU0942090050.USD","LU2023250843.SGD","SG9999001440.SGD","IHE","IE00BLSP4239.USD","FTXH","XLV","GDOC","LU0320765646.SGD","IYH","LU0069063385.USD","FHLC","LU0477156953.USD","VHT","LU0072461881.USD","BK4534","LU1917777945.USD","LU0868494617.USD","LU1066051498.USD","IE00BJT1NW94.SGD","LU2112291526.USD","HRTS","LU1035773651.USD","PAWZ","LU1989772923.USD","LU2468319806.SGD","SG9999014567.USD","LU1934455277.USD","LU1023059063.AUD","LU1061106388.HKD","LU2361045086.USD","LU0006306889.USD","LU2433249047.HKD","SG9999014559.SGD","LU1162221912.USD","LU0162691827.USD","LU1585245621.USD","BK4533","LU2023250504.SGD","LU0965509283.SGD","LU0070302665.USD","SG9999002224.SGD","IE00B2B36J28.USD","LU0265550359.USD","IE00BBT3K403.USD","IE00B1BXHZ80.USD","IE00BSNM7G36.USD","LU2125154935.USD","LU2491050071.SGD","BK4007","LU0289739343.SGD","IE00BN8TJ469.HKD","LU2361044865.SGD","LU2491049909.HKD","LU1941712348.USD","LU0320765489.SGD","LU0098860793.USD","LU1069347547.HKD","BK4588","LU2324357040.USD","LU1929549753.HKD","LU1989771016.USD","LU0823416689.USD","LU2491050154.USD","LU0289961442.SGD","LU0980610538.SGD","LU1093756168.USD","LU1066051225.USD","IE00BJJMRZ35.SGD","RXL","LU2089984988.USD","LU0965509010.AUD","LU0861579265.USD","LU0965508806.USD","MRK","LU1066053197.SGD","LU0432979614.USD","LU1037948541.HKD","LU0265550946.USD","LU0985320562.USD","LU1571399168.USD","LU1974910355.USD","LU0211331839.USD","LU0130517989.USD","LU0130102774.USD","LU0234572021.USD","SG9999014575.USD","LU0266013472.USD","BK4516","LU0689626769.HKD","IE00B4R5TH58.HKD","LU2461242641.AUD","LU2125154778.USD","LU1057294990.SGD","BK4550","LU1934455194.USD","SGXZ57979304.SGD","LU0511384066.AUD","LU1430594728.SGD","LU0058720904.USD","LU0472753341.HKD","SG9999002232.USD","BK4585","LU0122379950.USD","LU0965509101.SGD","PPH","JDOC","TRUH","LU1116320901.HKD","SG9999014542.SGD","LU1116320737.USD","BMED","LU0203347892.USD","LU0057025933.USD","LU0289739699.SGD","IE000M9KFDE8.USD","LU2106854487.HKD","LU0124676726.USD","LU0238689110.USD","LU2125909247.SGD","LU2357627491.SGD","LU0203345920.USD","SG9999015358.SGD","IE00BLSP4452.SGD","LU1201861249.SGD","LU1093756325.SGD","SG9999001176.USD","LU1983299246.USD","LU1941712264.USD","LU0208291251.USD","LU0648001328.SGD","LU1291159041.SGD","LU1923622614.USD","SG9999015341.SGD","IE0009355771.USD","LU1934455863.HKD","IXJ","LU0859254822.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490934","title":"FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490934?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:16","pubTimestamp":1790277398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G1BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203347892.USD","LU0432979614.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0130102774.USD","LU0265550359.USD","BK4588","LU0124676726.USD","LU0985320562.USD","LU1061106388.HKD","TRUH","LU2125154778.USD","LU2361044949.HKD","BK4585","LU1989772840.SGD","LU1201861249.SGD","LU0868494617.USD","LU1069347547.HKD","LU1066051225.USD","SG9999014567.USD","LU2089984988.USD","LU1989771016.USD","SG9999014559.SGD","LU0234572021.USD","BK4550","LU0203345920.USD","LU0289739699.SGD","LU0289739343.SGD","LU1066053197.SGD","LU2468319806.SGD","LU2491050154.USD","PPH","BK4533","LU0965509010.AUD","LU0162691827.USD","IE00BJT1NW94.SGD","SG9999001176.USD","SG9999002224.SGD","LU1941712264.USD","LU2023250843.SGD","LU0942090050.USD","LU2112291526.USD","LU0130517989.USD","LU0861579265.USD","IE000M9KFDE8.USD","SG9999001440.SGD","RXL","LU0965508806.USD","FTXH","LU0069063385.USD","LU1941712348.USD","LU2361044865.SGD","IE0009355771.USD","LU1571399168.USD","LU2361045086.USD","LU0072461881.USD","LU0289961442.SGD","BK4007","LU2125154935.USD","LU1023059063.AUD","LU1093756168.USD","SG9999014542.SGD","VHT","LU1923622614.USD","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU2324357040.USD","LU0320765646.SGD","LU0070302665.USD","SG9999014575.USD","LU2125909593.SGD","BK4534","LU0868494708.USD","XLV","LU0122379950.USD","IE00B1BXHZ80.USD","LU1116320737.USD","LU1116320901.HKD","IE00BLSP4239.USD","LU1035773651.USD","LU0511384066.AUD","LU0965509101.SGD","LU0266013472.USD","LU0265550946.USD","SG9999015358.SGD","SG9999001176.SGD","BK4516","LU0058720904.USD","LU1032466523.USD","LU2125909247.SGD","LU1974910355.USD","LU1585245621.USD","LU0477156953.USD","LU2433249047.HKD","IE00BBT3K403.USD","LU0238689110.USD","LU1430594728.SGD","LU2357627491.SGD","JDOC","SG9999002232.USD","SG9999013999.USD","LU1037948541.HKD","SG9999015341.SGD","LU0211331839.USD","LU1066051498.USD","LU1929549753.HKD","LU0965509283.SGD","LU1093756325.SGD","LU0057025933.USD","IYH","LU2023250504.SGD","LU1934455194.USD","LU2461242641.AUD","MRK","LU1989772923.USD","LU0472753341.HKD","LU0980610538.SGD","IHE","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","IE0002141913.USD","LU2491049909.HKD","LU0859254822.USD","LU2491050071.SGD","LU0320765489.SGD","LU1037948897.HKD","IXJ","BK4559","LU1934455277.USD","SGXZ57979304.SGD","IE00BSNM7G36.USD","LU1983299246.USD","BMED","LU0823416689.USD","LU2360032135.SGD","LU1162221912.USD","LU0106261372.USD","LU0098860793.USD","LU0006306889.USD","LU1066051811.HKD","LU1057294990.SGD","GDOC","IE00B4R5TH58.HKD","LU1699723380.USD","HRTS","LU1917777945.USD","LU0208291251.USD","LU0689626769.HKD","LU1934455863.HKD","PAWZ","FHLC","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492754","title":"Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492754","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492754?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:03","pubTimestamp":1790269423,"startTime":"0","endTime":"0","summary":"Merck  has two under-the-radar phase III catalysts due before year-end that carry low investor expectations, creating a positively skewed set up if either reads out positive, UBS said in a note emailed Thursday.The nearer one is phase III BRUNELLO data on MK3000, a Wnt agonist from Merck's 2024 Eyebio deal, in diabetic macular edema. Data is expected around an Oct. 10 placeholder at the American Academy of Ophthalmology meeting, with primary completion for the trial set for Sept. 30, the bank said.UBS said the drug need to prove non-inferiority to Lucentis on vision gains to meet its primary endpoint, while investors will likely demand superiority on a secondary endpoint.The bank also flagged phase III TL1A data due from a second ulcerative colitis study, acquired via the 2023 Prometheus deal, as a second overlooked catalyst.UBS maintained its buy rating on the stock with the price target of $175.Price: 149.64, Change: +1.55, Percent Change: +1.05","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006306889.USD","LU1162221912.USD","LU1066051811.HKD","LU2361044865.SGD","LU1430594728.SGD","BMED","LU0265550359.USD","LU2125154778.USD","IXJ","XLV","LU0106261372.USD","LU0122379950.USD","LU2491049909.HKD","LU2461242641.AUD","LU2106854487.HKD","IE00B1BXHZ80.USD","LU1066051498.USD","LU1093756168.USD","RXL","LU0289739343.SGD","LU1116320901.HKD","LU0234572021.USD","LU0203345920.USD","LU0868494708.USD","LU1037948541.HKD","SG9999001176.SGD","LU0868494617.USD","LU0477156953.USD","LU0980610538.SGD","LU2468319806.SGD","LU1941712348.USD","SG9999014542.SGD","LU0859254822.USD","LU2125154935.USD","BK4550","LU0823416689.USD","IE00B4R5TH58.HKD","SG9999001176.USD","LU0985320562.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU0861579265.USD","LU0320765646.SGD","FHLC","IE00BJT1NW94.SGD","LU0124676726.USD","IE00BN8TJ469.HKD","LU2023250843.SGD","LU2491050154.USD","LU1934455194.USD","BK4585","BK4559","BK4588","LU1934455277.USD","LU0069063385.USD","LU0098860793.USD","SGXZ57979304.SGD","LU1941712264.USD","LU1983299246.USD","GDOC","PAWZ","SG9999002232.USD","IHE","IE0009355771.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","LU1066051225.USD","SG9999014575.USD","LU0648001328.SGD","LU1093756325.SGD","LU0432979614.USD","LU0070302665.USD","LU0511384066.AUD","LU2125909593.SGD","LU1057294990.SGD","LU0265550946.USD","FTXH","LU0208291251.USD","LU1917777945.USD","SG9999014567.USD","LU1201861249.SGD","LU0689626769.HKD","LU2360032135.SGD","SG9999014559.SGD","LU0203347892.USD","LU1061106388.HKD","LU2089984988.USD","LU0942090050.USD","LU1974910355.USD","HRTS","LU0965508806.USD","LU0238689110.USD","LU1035773651.USD","LU1923622614.USD","MRK","LU0320765489.SGD","BK4534","IE0002141913.USD","LU2125909247.SGD","IE00BSNM7G36.USD","LU2023250504.SGD","IE00BLSP4239.USD","LU0472753341.HKD","LU0965509101.SGD","LU1066053197.SGD","SG9999002224.SGD","LU1989772923.USD","LU2491050071.SGD","JDOC","LU0130102774.USD","IE00BBT3K403.USD","LU2357627491.SGD","LU1023059063.AUD","TRUH","LU0057025933.USD","SG9999015341.SGD","LU0058720904.USD","LU1699723380.USD","LU1116320737.USD","LU1934455863.HKD","LU2324357040.USD","SG9999015358.SGD","LU1989771016.USD","LU1929549753.HKD","LU0965509283.SGD","LU1571399168.USD","SG9999013999.USD","IYH","LU1291159041.SGD","LU1585245621.USD","LU1037948897.HKD","BK4007","LU2361045086.USD","LU0289961442.SGD","BK4533","LU2112291526.USD","LU0162691827.USD","IE00BLSP4452.SGD","VHT","LU2361044949.HKD","LU2433249047.HKD","LU0130517989.USD","LU1069347547.HKD","LU1032466523.USD","BK4516","SG9999001440.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","LU0266013472.USD","PPH","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492787","title":"Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492787","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492787?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:02","pubTimestamp":1790269368,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics'  lead program of long-acting IL-23 in moderate-to-severe psoriasis maintains a \"competitive profile\" after positive week 28 clinical data, UBS said in a Wednesday note.Oruka's ORKA-001 increased its Psoriasis Area and Severity Index-100 score, which represents the complete resolution of psoriasis, to 71% from 64% in week 16. This compares favorably with rival product, AbbVie's  Skyrizi, which rose to 53% from 43% in the same period, UBS analysts said.The safety data was also consistent with prior data, as treatment-emergent adverse events were 36% in the period of week 16 to 28, compared with 51% during week zero to 16. There were also no injection site reactions and no impact of anti-drug antibodies on safety, efficacy and pharmacokinetics, the analysts noted.The analysts said they are confident in the company's multiple additional readouts later in the year to be positive, \"given the de-risking provided by previous datasets\".UBS' rating on the company's stock is b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z3B42.SGD","LU0432979614.USD","GLAM","LU0029864427.USD","MEDX","ABBV","LU0256863902.USD","RXL","IXJ","LU0795875169.SGD","IE000WAW04H5.SGD","LU0289961442.SGD","LU1003077747.HKD","PJP","BK4550","FHLC","IYH","PPH","IE000F7OJYX1.SGD","LU1093756168.USD","LU0114720955.EUR","JDOC","AGNG","LU0985320562.USD","LU2129689514.USD","LU0198837287.USD","XLV","LU0124676726.USD","IE00BVYPNW00.USD","IE00BLSP4239.USD","LU0320765646.SGD","ORKA","SG9999015986.USD","LU0395794307.EUR","BK4007","LU1934455863.HKD","SG9999001440.SGD","VHT","LU2133065610.SGD","BK4585","LENZ","IE00BSNM7G36.USD","LU2237443549.SGD","TRUH","LU0511384066.AUD","IE00BN8TJ469.HKD","LU0211327993.USD","LU0256863811.USD","BK4588","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494748","title":"Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670494748?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:03","pubTimestamp":1790265780,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B rose 0.3% to DKK253.00 Thursday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.3% to 2,614.61.The stock's rise  snapped a three-day losing streak.The company closed DKK156.95 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 7,386,035, compared to the 50-day average trading volume of 4,650,963.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVOH","BK4532","NVOC","PPH","BK4585","NVO","BK4599","OZEM","LU0154236417.USD","NVOX","IE00BKVL7J92.USD","THNR","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670149441","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2670149441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670149441?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:00","pubTimestamp":1790265608,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeEverpure IncP.N+18.4%Charles River Laboratories International, Inc.CRL.N+5.2%Valero Energy CorpVLO.N+4.0%Illumina IncILMN.OQ+3.7%Eli Lilly and CompanyLLY.N+3.4%Bottom PerformersPercent ChangeMGM Resorts InternationalMGM.N-10.2%Gen Digital Inc.GEN.OQ-8.2%First Solar, Inc.FSLR.OQ-7.5%Rollins IncROL.N-6.2%Bloom Energy CorporationBE.N-5.9%As of 12:00 p.m., the S&P 500.SPXlost 33.07 points, or 0.43%, to 7,673.06 and had posted 10 new 52-week highs and 36 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL8N45G1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957808578.USD","SG9999015952.SGD","LU2461242641.AUD","IE00B7KXQ091.USD","LU1430594728.SGD","FENY","IE00BKPKM429.USD","IXJ","LU0823416689.USD","JEPI","LU1988902786.USD","LU2048586759.USD","LU2211815571.USD","WEEI","LU1979441026.SGD","SG9999015945.SGD","ICLN","LU1868836591.USD","LU2237443895.HKD","LU0124384867.USD","CANC","ITOT","LU2237438978.USD","SPYG","IE00B4R5TH58.HKD","IE00BGHQF417.EUR","IE00B1BXHZ80.USD","PXE","LU1551013425.SGD","LU1035775433.USD","ETFT","LU2168564065.EUR","PXI","LU0006306889.USD","BEC","LU0385154629.USD","LU2028103732.USD","LU1280957306.USD","SGXZ51526630.SGD","LU2756315664.SGD","LU2896262040.SGD","LU2294711713.HKD","LU2125909916.SGD","IE0004445015.USD","SGXZ31699556.SGD","LU1323610961.USD","SPXU","HYDR","LU2468319806.SGD","LU2264538146.SGD","LU0476273544.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU0323239441.USD","RSPA","LU0432979614.USD","IE00BWXC8680.SGD","LU1923622291.USD","ROL","LU2491050071.SGD","LU0198837287.USD","BK4120","LU2265009873.SGD","LU0256863902.USD","XDTE","AGNG","LU0823414551.USD","PUL","SCHB","LU2023251221.USD","LU1815336760.USD","LU0128526141.USD","ZAP","LU0823421333.USD","GSLC","LU0109394709.USD","UPGR","LU0174119429.USD","CRAK","LU0094547139.USD","LU0238689110.USD","LU2089284900.SGD","VTI","ELIS","LU1868837300.USD","SPYQ","LU0058720904.USD","TMED","GB00BDT5M118.USD","LU2746668974.SGD","LU0256863811.USD","LU0820561818.USD","LU0097036916.USD","LU1804176565.USD","LU0170899867.USD","LU0943347566.SGD","LU0133085943.USD","SPHD","LU0234572021.USD","LU0683600562.USD","LU2357125470.USD","IE0002141913.USD","BK4097","LU2087625088.SGD","LU2360106947.USD","SPYV","IE0009355771.USD","LU0345770308.USD","YSPY","VV","GXPE","LU2237443549.SGD","IE00BJJMRY28.SGD","LU2271345857.HKD","IVV","NOBL","LU1629891620.HKD","LU0203202063.USD","LU2023250330.USD","MHIP","LU0323240290.USD","LU2168564222.USD","IYH","LU1989771016.USD","IE00BGHQF524.EUR","LU0823434583.USD","DBSC","MEDX","IE00B2Q91V27.USD","LU0096364046.USD","LU0122379950.USD","SGXZ99366536.SGD","IE00BFSS8Q28.SGD","LU2361044865.SGD","LU0154245673.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU1023059063.AUD","WDNA","LLII","LU1057294990.SGD","BK4150","EGGY","SPUU","LU1093756325.SGD","IE00BSNM7G36.USD","LU0689472784.USD","PJP","LU0320765992.SGD","JDOC","BK4170","LU2168564495.EUR","LU0823434740.USD","IEO","LU0708995401.HKD","FRNW","LU0345781412.USD","ILMN","BE","LU0106261372.USD","IVE","BK4535","TNGY","LU2125909759.SGD","LU2543165471.USD","LU1992135399.USD","SG9999014880.SGD","VEU","LU1623119135.USD","LU0471298777.SGD","LU0312595415.SGD","VHT","LU0029874061.USD","MOAT","RSP","SG9999018857.SGD","IBAT","LU1093756168.USD","IE0004445239.USD","LU2491049909.HKD","LU0354030438.USD","MGM","IE00BK4W5L77.USD","LU2750360641.GBP","LU2272731782.SGD","THNR","BK4141","LU2111349929.HKD","LLYX","SGXZ57979304.SGD","LU0466842654.USD","LU1917777945.USD","SPGP","LU0158827781.USD","ACWI","LU0154245756.USD","LU0788109394.HKD","BK4530","LLY","LU1712237335.SGD","XLV","LU1232071149.USD","SCHX","SG9999014898.SGD","WATS","IE00BJJMRZ35.SGD","CURE","MEDI","IYE","SGXZ81514606.USD","RSPG","LU1868836914.USD","LU2471134796.USD","LU1720051017.SGD","LU2237443465.HKD","LU0323591593.USD","LU2237443978.SGD","LU0109391861.USD","SMOG","LU2063271972.USD","OZEM","LU0061475181.USD","IE0001KFT4U8.USD","GPIX","SPXS","LU2552382215.SGD","LU0210536198.USD","LU2602419157.SGD","P","LU0640476718.USD","FTXH","LU2089283258.USD","LU1571399168.USD","LU1868836757.USD","LU1814569148.SGD","LU1267930730.SGD","IE00BKDWB100.SGD","RSPN","LU2756315318.SGD","LU2298322129.HKD","BK4182","LU0444973449.USD","LU0786609619.USD","SG9999001176.SGD","BEX","LU2462591350.SGD","LU2473716301.USD","TRUH","LU0820561909.HKD","BK4516","LU1069344957.HKD","VTWG","LU0266512473.USD","SG9999001176.USD","LU1978683503.SGD","LLYZ","IE00BJLML261.HKD","IE00BFMHRM44.USD","SG9999001440.SGD","LU2471134523.USD","IVW","LU0225283273.USD","BK4541","LU1064131342.USD","LU0823421416.USD","LU2249611893.SGD","BK4121","LU2471134879.HKD","LU0672654240.SGD","SPUS","LU0820562030.AUD","UPRO","SPDN","IE00B2B36J28.USD","BK4561","LU2322448791.USD","IJH","VLO","LU1061106388.HKD","IE0005OL40V9.USD","BK4585","CTEC","VOO","SG9999018865.SGD","HRTS","SMAX","SG9999013999.USD","VTV","LU0964807845.USD","LU0889565916.HKD","LU0724618433.USD","SG9999017495.SGD","LU2106854487.HKD","LU0345780950.USD","LU0079474960.USD","HIBS","SPYD","LU1720051108.HKD","IJR","LU0114720955.EUR","VBK","LU2023250504.SGD","LU1145028129.USD","SH","BK4599","DRLL","LU0456855351.SGD","LU0417517546.SGD","SFY","LU2286300806.USD","LU0158827948.USD","BK4519","IE00BFTCPJ56.SGD","LU0882574139.USD","LU1291159041.SGD","BK4138","LU1983299246.USD","SPY","BK4533","LU0300736492.USD","LU0368265418.SGD","LU2213496289.HKD","BK4548","LU2112291526.USD","PPH","LU2471134952.CNY","BEG","SPXL","LU2552382058.USD","XLE","SPYH","FSLR","LU1868837136.USD","SDS","LU0390134368.USD","VOOG","ILDR","ODDZ","IE00B3CCJ963.GBP","LU2237443622.USD","LU2506951792.HKD","TAN","LU1815336091.USD","LU0630314457.HKD","LU1366192091.USD","LU1974910355.USD","BK4534","LU0266013472.USD","LU0757428866.USD","BMAY",".SPX","GNMX","SG9999015986.USD","IE00B2PGVK34.USD","LU2361044949.HKD","IE00BJJMRX11.SGD","ALLW","LU1548497426.USD","LU0353189680.USD","LU2357305700.SGD","BK4007","LU2272731600.USD","IE00BK4W5M84.HKD","LU0316494557.USD","MMAX","IE00B1XK9C88.USD","LU2211814178.USD","IE00BN29S564.USD","DMAX","BK4596","LU2272731865.HKD","LU0266512127.USD","BK4581","LU2168563687.JPY","SSO","SPLV","LU2168564149.EUR","LU2462157665.USD","SIMS","GNOM","XYLD","LU1127390331.HKD","IE0009354923.USD","FHLC","LU1691799644.USD","LU0787776722.HKD","VCLN","SPMO","LU2417539215.USD","LU0289739699.SGD","RSPU","SG9999014914.USD","GDOC","LU0882574055.USD","LU2491050154.USD","SPYU","LU0823414478.USD","SG9999015978.USD","TRUN","LU1551013342.USD","BK4588","IE00B4JS1V06.HKD","LU2746668461.USD","LU2108987350.USD","GEN","LU2750360997.AUD","LU0353189763.USD","LU0471298694.HKD","IE00B3CCJ633.GBP","SG9999014906.USD","CRL","LU1983299162.USD","IHE","LU1992135472.HKD","ELIL","LU2324357040.USD","LU0444971666.USD","RXL","LU2552382132.HKD","SPHQ","LU2237443382.USD","LU2361045086.USD","BEZ","LU2456880835.USD","IE00B775H168.HKD","LU0122376428.USD","LU1585245621.USD","TSPY","LU0203201768.USD","CNRG","LU1642822529.SGD","LU2322448957.HKD","LU0456854461.SGD","HIBL","XLG","LU2089984988.USD","LU2236285917.USD","SPYM","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149622","title":"Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149622","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149622?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:15","pubTimestamp":1790259318,"startTime":"0","endTime":"0","summary":"• FDA approved Eli Lilly's once-weekly basal insulin Onswik for type 2 diabetes.\n• Eli Lilly reported $65.18B annual revenue and $20.64B net profit.\n• Analysts rate the stock as Buy with an average price target of $1306.81.","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185188-market-movers-lly-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU2468319806.SGD","SG9999015986.USD","LU0823434583.USD","IE00B775H168.HKD","IXJ","AGNG","LU1712237335.SGD","SG9999015945.SGD","LU0345770308.USD","LU1691799644.USD","LU1057294990.SGD","SG9999015952.SGD","SG9999013999.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU2211815571.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1323610961.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0106261372.USD","LU0256863811.USD","LU1917777945.USD","LU2462591350.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1093756168.USD","BK4581","SG9999014880.SGD","LU1988902786.USD","LU0266013472.USD","LU2168564149.EUR","LU2265009873.SGD","LU0058720904.USD","LU0456855351.SGD","LU0316494557.USD","LU0256863902.USD","IE0009355771.USD","LU2237443465.HKD","LU2237443382.USD","HRTS","LU2213496289.HKD","IE00B7KXQ091.USD","LLYX","LU2237443978.SGD","LU1127390331.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2471134952.CNY","LU0964807845.USD","ELIL","SG9999018857.SGD","LU2750360997.AUD","LU0289739699.SGD","LU2108987350.USD","SG9999001176.USD","LU1280957306.USD","LU0158827948.USD","LU0672654240.SGD","PPH","SG9999001176.SGD","XLV","LU0097036916.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2552382058.USD","LU0238689110.USD","LU1720051108.HKD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU0198837287.USD","LU0353189680.USD","LU0354030438.USD","LU1551013425.SGD","BK4007","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1069344957.HKD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0786609619.USD","IE00BN29S564.USD","LU2750360641.GBP","LU1868836757.USD","LU0203201768.USD","LU0385154629.USD","LU2360106947.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0079474960.USD","LU2552382215.SGD","LU0158827781.USD","RXL","LU2552382132.HKD","LU0323591593.USD","LU1974910355.USD","SG9999018865.SGD","LU2168564222.USD","LU1623119135.USD","BK4533","MEDX","LU0225283273.USD","GDOC","LU2089283258.USD","ILDR","LU1232071149.USD","LU1979441026.SGD","LU2063271972.USD","LU2746668974.SGD","LLII","LU1804176565.USD","LU0320765992.SGD","LU1814569148.SGD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1291159041.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU2023251221.USD","OZEM","LU1023059063.AUD","LLYZ","CURE","LU1868836591.USD","LU2462157665.USD","LU2471134796.USD","LU1035775433.USD","LLY","LU1989771016.USD","LU2361044949.HKD","LU2361045086.USD","SG9999015978.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2491049909.HKD","LU2602419157.SGD","LU0320765059.SGD","LU1983299246.USD","LU1366192091.USD","BK4599","IE0005OL40V9.USD","LU0210536198.USD","IE0004445015.USD","IYH","LU2028103732.USD","LU0122379950.USD","LU2324357040.USD","LU1548497426.USD","LU0174119429.USD","LU0234572021.USD","LU0109394709.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0353189763.USD","IE00BJT1NW94.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU2237443622.USD","LU1061106388.HKD","BK4588","PJP","LU2756315318.SGD","LU0823416689.USD","TRUH","LU0820561818.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0432979614.USD","LU2456880835.USD","WDNA","BK4585","LU2237443895.HKD","LU0094547139.USD","IE00BFSS7M15.SGD","LU0683600562.USD","BK4534","LU0823434740.USD","LU2237438978.USD","SG9999014914.USD","LU0640476718.USD","FTXH","LU2896262040.SGD","MEDI","VHT","IE00B1BXHZ80.USD","LU2264538146.SGD","LU1629891620.HKD","LU2271345857.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0006306889.USD","IE0004445239.USD","LU0345770993.USD","THNR","LU0417517546.SGD","IE0002141913.USD","LU2236285917.USD","LU0466842654.USD","LU2237443549.SGD","ELIS","IE00B4JS1V06.HKD","LU1868837300.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU2746668461.USD","TMED","LU1093756325.SGD","SG9999014898.SGD","LU2087625088.SGD","LU2089984988.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2023250330.USD","LU2417539215.USD","LU0133085943.USD","CANC","LU0820562030.AUD","LU2111349929.HKD","BK4516","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2491050154.USD","MHIP","LU1551013342.USD","SG9999014906.USD","LU1267930730.SGD","LU0109391861.USD","LU2168564495.EUR","LU0096364046.USD","LU1868837136.USD","LU0943347566.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669449501","title":"Novartis Poised for Sales Growth Acceleration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669449501","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669449501?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:55","pubTimestamp":1790258100,"startTime":"0","endTime":"0","summary":"1355 GMT - Novartis CEO Vas Narasimhan is confident in the midterm outlook for the company, with drug launches set to lift top-line growth next year, Bank of America analysts say. Speaking at a Bank of America conference, Narasimhan struck a bullish tone on the Swiss drugmaker's prospects for the 2026-31 period and signaled previous guidance of sales growth of 5% to 6% in the five years through 2030 would be extended to 2031 at an update scheduled for November, the analysts say. Sales growth looks set to accelerate next year relative to the second half of 2026, when the company expects to post a mid single-digit percentage increase, and its performance at the end of the fourth quarter will be the best proxy, the analysts add. Shares rise 1.5%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","IE00BLSP4239.USD","LU0640476718.USD","FNCL","LU0130103400.USD","LU1496350171.SGD","TFNS","VFH","IE0002141913.USD","LU2129689514.USD","LU0477156953.USD","LU0648001328.SGD","LU0234570918.USD","IYF","PPH","UYG","LU0306807586.USD","BK4585","LU1280957306.USD","KBWB","BK4581","LU1162221912.USD","FTXO","LU1267930227.SGD","LU0203345920.USD","NVS","LU0130518102.USD","LU0052756011.USD","LU0211331839.USD","IE00BJJMRZ35.SGD","LU0053666078.USD","IE00BBT3K403.USD","LU0306806265.USD","LU1291159041.SGD","IYG","MEDX","BK4007","LU1201861165.SGD","LU2596442595.SGD","LU1989771016.USD","LU1894683348.USD","XLF","IE0002270589.USD","LU0683600562.USD","LU0170899867.USD","LU0320765489.SGD","LU1496350502.SGD","BK4532","LU0314106906.USD","BAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149540","title":"Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149540?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:46","pubTimestamp":1790257597,"startTime":"0","endTime":"0","summary":"BUZZ-Lilly's next-gen obesity efforts could tip scales further in its favor, Citi says** Eli LillyLLY.Nis expected to present mid-stage data next week on eloralintide, its next-generation obesity drug candidate, in combination with its blockbuster weight-loss drug Zepbound, chemically known as tirzepatide** Citi analysts say the data will be a test of whether eloralintide can extend tirzepatide's efficacy without compromising tolerability or persistence** Eloralintide belongs to the class of drugs that mimic the pancreatic hormone amylin with the potential of less severe side effects than the popular GLP-1 class of drugs** Citi says 16 to 18% weight loss would be a \"solid readout with over 18% being a clean win to further diversify Lilly's obesity portfolio, expand coverage across patient needs, and provide greater treatment flexibility\"** A 9-milligram dose of eloralintide had helped patients lose about20.1%or 21.3 kgs in a mid-stage study last year** Up to last close, LLY up ~7% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LLII","LU1057294990.SGD","LU1548497426.USD","LU2471134796.USD","SG9999014880.SGD","LU0256863811.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","BK4007","PPH","LU2023250504.SGD","RXL","LU1988902786.USD","LU1069344957.HKD","LU2236285917.USD","SG9999018857.SGD","LU2468319806.SGD","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999015945.SGD","LU1145028129.USD","LU1366192091.USD","WDNA","LU2491049909.HKD","LU1868837136.USD","SG9999015986.USD","TRUH","IE00BFSS7M15.SGD","LU2750360997.AUD","MEDX","LU1035775433.USD","LU1868836914.USD","CANC","OZEM","LU0417517546.SGD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0432979614.USD","LU0471298777.SGD","LU0385154629.USD","LU0882574055.USD","LU1280957306.USD","LU2361044949.HKD","MEDI","LU0106261372.USD","BK4585","IE0009355771.USD","LU0820561909.HKD","THNR","LU1989771016.USD","MHIP","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","LU1061106388.HKD","FTXH","SG9999013999.USD","LU2746668461.USD","SGXZ81514606.USD","LU0158827781.USD","LU2491050154.USD","LU0345770308.USD","LU0353189680.USD","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","LU0234572021.USD","LU0058720904.USD","ILDR","TMED","LU0471298694.HKD","LU2750360641.GBP","SGXZ51526630.SGD","LU0466842654.USD","LU0820561818.USD","LU2237443549.SGD","BK4534","LU0203201768.USD","SG9999014898.SGD","LU2471134879.HKD","LU0823434583.USD","LU0672654240.SGD","LU2112291526.USD","LU2023251221.USD","LU2168564065.EUR","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU2168564495.EUR","IXJ","VHT","LU0823416689.USD","LU0354030511.USD","LU1093756168.USD","LU0787776722.HKD","GB00BDT5M118.USD","IE0004445239.USD","LU2089283258.USD","LU0079474960.USD","LU2462157665.USD","LU0109391861.USD","SG9999015978.USD","LLY","LU0198837287.USD","LU0354030438.USD","LU1064131342.USD","LU0882574139.USD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868837300.USD","SGXZ31699556.SGD","LLYZ","LU1623119135.USD","IE00BK4W5L77.USD","LU0320765992.SGD","LU2265009873.SGD","GDOC","LU0708995401.HKD","LU0456855351.SGD","LU0889565916.HKD","SG9999014906.USD","AGNG","IE00B775H168.HKD","LU2271345857.HKD","LU0158827948.USD","LU2602419157.SGD","IE00BKDWB100.SGD","LU1232071149.USD","IE00BJJMRX11.SGD","CURE","LU0683600562.USD","LU1720051017.SGD","SG9999014914.USD","BK4599","LU2106854487.HKD","IE00B1XK9C88.USD","LU1974910355.USD","IYH","BK4588","LU0640476718.USD","LU2237443978.SGD","LU2471134523.USD","LU2108987350.USD","LU1868836591.USD","IE00B4JS1V06.HKD","LU2417539215.USD","LU0786609619.USD","LU2462591350.SGD","LU0943347566.SGD","LU2361044865.SGD","SG9999001176.USD","PJP","XLV","LU0256863902.USD","LU2324357040.USD","LU0006306889.USD","LU0689472784.USD","LU1691799644.USD","LU1720051108.HKD","LU1868836757.USD","IE00BK4W5M84.HKD","LU2168564222.USD","SG9999015952.SGD","ELIL","IE00BJLML261.HKD","LU2168563687.JPY","LU2237443382.USD","IHE","LU2896262040.SGD","LU1979441026.SGD","LU0353189763.USD","LU1291159041.SGD","LU2111349929.HKD","LU2237438978.USD","ELIS","LU1551013342.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1093756325.SGD","LU0109394709.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2168564149.EUR","LU2089284900.SGD","LU1127390331.HKD","HRTS","LU0964807845.USD","LU2237443895.HKD","LU2746668974.SGD","LU2063271972.USD","IE00B2B36J28.USD","IE0004445015.USD","LU0316494557.USD","SG9999018865.SGD","LU2089984988.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2237443465.HKD","LLYX","LU0133085943.USD","IE00BFSS8Q28.SGD","LU1983299246.USD","LU2461242641.AUD","LU2213496289.HKD","LU0094547139.USD","IE0002141913.USD","SGXZ57979304.SGD","LU0823434740.USD","LU2471134952.CNY","LU2756315664.SGD","LU2756315318.SGD","LU0266013472.USD","BK4581","LU0174119429.USD","LU1917777945.USD","LU2028103732.USD","LU2264538146.SGD","FHLC","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2237443622.USD","LU0345770993.USD","LU2361045086.USD","JDOC","LU0061475181.USD","BK4516","LU0096364046.USD","LU2491050071.SGD","LU2552382132.HKD","LU0097036916.USD","LU0114720955.EUR","LU0122379950.USD","IE00BJJMRY28.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462942","title":"Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462942","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462942?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:04","pubTimestamp":1790247879,"startTime":"0","endTime":"0","summary":"UPDATE 3-Merck's drug for diabetes-related eye disease meets trial goalSept 24 (Reuters)-MerckMRK.Nsaid on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","GDOC","JDOC","LU0006306889.USD","LU0965509283.SGD","IE00B2B36J28.USD","LU0266013472.USD","BK4007","LU0098860793.USD","LU1061106388.HKD","IXJ","IE000M9KFDE8.USD","TRUH","LU2324357040.USD","LU1989772840.SGD","IYH","HRTS","RXL","VHT","PAWZ","LU0472753341.HKD","LU0203347892.USD","LU1934455277.USD","LU2433249047.HKD","LU0122379950.USD","LU1066051498.USD","LU1116320901.HKD","PPH","LU0477156953.USD","BK4550","BMED","LU2023250504.SGD","SG9999014559.SGD","SG9999015341.SGD","LU2125154935.USD","LU0289739699.SGD","SG9999002224.SGD","FTXH","BK4516","XLV","LU0289739343.SGD","BK4559","LU2491049909.HKD","LU1989771016.USD","MRK","IHE","LU0511384066.AUD","LU0985320562.USD","SG9999001440.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669629644","title":"Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2669629644","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669629644?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:03","pubTimestamp":1790247822,"startTime":"0","endTime":"0","summary":"Health Canada approves AbbVie’s EPKINLY combo for relapsed or refractory follicular lymphoma in adultsHealth Canada cleared AbbVie’s EPKINLY (epcoritamab) with lenalidomide, rituximab for relapsed or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLbtn36S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350171.SGD","PPH","LU0310799852.SGD","IE000MB6IJN5.SGD","SG9999011175.SGD","LU2237443465.HKD","JDOC","AGNG","LU2347655073.USD","LU1093756168.USD","MEDX","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0310800379.SGD","RXL","LU0820561909.HKD","LU0859254822.USD","VHT","IXJ","SG9999003800.SGD","LU1670627923.USD","LU0417517546.SGD","IE00BN8TJ469.HKD","FHLC","FTXH","LU0708994859.HKD","TRUH","IE0002270589.USD","SG9999015945.SGD","LU0114720955.EUR","BK4533","LU1934455863.HKD","LU0069063385.USD","IYH","LU2357305700.SGD","GLAM","LU0289961442.SGD","IE00BGHQF631.EUR","XLV","LU2237443895.HKD","IE00BLSP4239.USD","LU0965509101.SGD","PJP","LU1291159041.SGD","LU1037948897.HKD","SG9999015978.USD","ABBV","LU0553294199.USD","LU0661504455.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669625764","title":"Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2669625764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669625764?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:01","pubTimestamp":1790247660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA7YJCP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","VHT","BK4588","IYH","JDOC","FHLC","BK4139","LU0124676726.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","TRUH","IXJ","PJP","PPH","LU0985320562.USD","IE00BGHQF631.EUR","LU1934455277.USD","LU0823416689.USD","LU0057025933.USD","LU1244550494.USD","LU1989771016.USD","LU0289739343.SGD","IE00BJT1NW94.SGD","LU0708994859.HKD","LU1267930573.SGD","LU2129689431.USD","BK4566","RXL","ABBV","LU2237443978.SGD","LU1430594728.SGD","LU0943347566.SGD","GLAM","FTXH","IE0002141913.USD","LU1983299246.USD","XLV","LU2087621335.USD","LU1236620750.USD","LU0472753341.HKD","LU0122379950.USD","LU0456855351.SGD","LU0661504455.SGD","AGNG","LU2125909247.SGD","LU2023251221.USD","IE000BZT7R73.USD","LU0114720955.EUR","IE00BLSP4239.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462376","title":"Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462376","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462376?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:59","pubTimestamp":1790247540,"startTime":"0","endTime":"0","summary":"Eli Lilly has won U.S. Food and Drug Administration approval for Onswik, a once-weekly basal insulin injection treatment for adults with type 2 diabetes.Eli Lilly on Thursday said Onswik is designed to deliver steady basal insulin levels over seven days, eliminating the need for more than 300 injections a year compared to once-daily basal insulin.The Indianapolis drugmaker said the Onswik KwikPen will be available in the U.S. in the coming months.Onswik was previously approved for adults with type 2 diabetes in Europe, Mexico and Japan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LLY","LU0266013472.USD","IE00BWXC8680.SGD","IXJ","LU0432979614.USD","LLYZ","LLYX","LU0079474960.USD","ILDR","LU0320765059.SGD","LU1629891620.HKD","LU0640476718.USD","LU2324357040.USD","PJP","IE00B7KXQ091.USD","LU0823416689.USD","SG9999015945.SGD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU2471134879.HKD","LU0316494557.USD","LU0353189763.USD","LU1291159041.SGD","LU0096364046.USD","LU0133085943.USD","LU0158827948.USD","SG9999018857.SGD","IE00BJLML261.HKD","TMED","AGNG","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","LLII","BK4585","LU2264538146.SGD","IE00BJT1NW94.SGD","LU0471298694.HKD","LU1974910355.USD","LU2756315664.SGD","WDNA","LU2271345857.HKD","SGXZ31699556.SGD","LU0823434583.USD","ELIL","ELIS","LU1023059063.AUD","LU1366192091.USD","LU1988902786.USD","LU2211815571.USD","LU2750360641.GBP","LU0109394709.USD","LU1712237335.SGD","LU1868836914.USD","LU0943347566.SGD","IE00BKPKM429.USD","BK4007","SGXZ51526630.SGD","LU1979441026.SGD","LU0094547139.USD","LU2361044949.HKD","IYH","LU2360106947.USD","LU1064131342.USD","LU1061106388.HKD","IE0004445015.USD","LU0823434740.USD","LU1691799644.USD","LU1267930730.SGD","LU0466842654.USD","LU2106854487.HKD","LU0345770993.USD","LU2028103732.USD","LU0174119429.USD","LU2361045086.USD","LU0061475181.USD","SG9999013999.USD","JDOC","IE00B4R5TH58.HKD","GDOC","LU0114720955.EUR","LU0689472784.USD","LU0320765992.SGD","LU1868836591.USD","LU2456880835.USD","LU1232071149.USD","VHT","LU2112291526.USD","BK4516","BK4581","IE00B2B36J28.USD","LU2063271972.USD","IE0005OL40V9.USD","LU2023251221.USD","LU2213496289.HKD","LU1720051108.HKD","LU2462157665.USD","LU1551013342.USD","IE0009355771.USD","LU2089284900.SGD","TRUH","LU1814569148.SGD","LU2237443465.HKD","LU0234572021.USD","SG9999015986.USD","BK4588","LU0456855351.SGD","LU0006306889.USD","LU0158827781.USD","HRTS","IE00BN29S564.USD","LU0198837287.USD","OZEM","LU1093756168.USD","SG9999001176.USD","LU0672654240.SGD","LU0820562030.AUD","LU2023250330.USD","LU1093756325.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0122379950.USD","LU2552382132.HKD","LU0256863902.USD","IE00BFSS8Q28.SGD","LU0354030438.USD","LU0385154629.USD","LU0882574055.USD","LU1057294990.SGD","LU2237443978.SGD","LU2462591350.SGD","LU0238689110.USD","LU2896262040.SGD","LU2237443382.USD","IE0001KFT4U8.USD","LU0889565916.HKD","IE00B1XK9C88.USD","LU2089283258.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU2111349929.HKD","LU2237438978.USD","LU2471134952.CNY","LU2552382058.USD","LU2168564149.EUR","LU2746668461.USD","LU0225283273.USD","MEDI","LU2461242641.AUD","FTXH","IE00B775H168.HKD","LU0820561909.HKD","LU2468319806.SGD","LU0820561818.USD","LU2602419157.SGD","LU2087625088.SGD","FHLC","LU1720051017.SGD","IE00BK4W5L77.USD","LU0058720904.USD","LU0417517546.SGD","IE00B4JS1V06.HKD","LU2491050154.USD","LU0708995401.HKD","SG9999015978.USD","LU1868837136.USD","LU2552382215.SGD","LU2746668974.SGD","LU0787776722.HKD","LU0203201768.USD","BK4534","MHIP","LU0109391861.USD","LU1917777945.USD","LU2089984988.USD","LU2237443549.SGD","LU2756315318.SGD","IE0004445239.USD","PPH","LU0786609619.USD","LU2417539215.USD","RXL","LU2168564222.USD","LU2236285917.USD","LU0323591593.USD","LU2237443622.USD","LU2471134796.USD","IE00BKDWB100.SGD","SGXZ99366536.SGD","LU2237443895.HKD","LU1989771016.USD","LU0964807845.USD","LU1623119135.USD","SG9999017495.SGD","LU1551013425.SGD","LU2168564495.EUR","LU2471134523.USD","LU2750360997.AUD","LU1127390331.HKD","LU0353189680.USD","LU0256863811.USD","SG9999014914.USD","IHE","THNR","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2361044865.SGD","IE00BFSS7M15.SGD","LU0210536198.USD","LU2357305700.SGD","SG9999014898.SGD","BK4533","LU1035775433.USD","SGXZ81514606.USD","CURE","XLV","MEDX","LU1069344957.HKD","LU1804176565.USD","LU0203202063.USD","LU1145028129.USD","SG9999015952.SGD","CANC","LU1983299246.USD","LU2023250504.SGD","LU0106261372.USD","LU1548497426.USD","LU1280957306.USD","LU1868836757.USD","LU0097036916.USD","LU2265009873.SGD","IE00BJJMRX11.SGD","LU2168563687.JPY","SG9999014906.USD","LU2108987350.USD","BK4599","LU0471298777.SGD","LU0882574139.USD","LU0354030511.USD","IE00BJJMRY28.SGD","LU0345770308.USD","LU1323610961.USD","SG9999014880.SGD","LU0683600562.USD","SG9999018865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464279","title":"Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464279","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464279?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:46","pubTimestamp":1790246767,"startTime":"0","endTime":"0","summary":"Merck says remigromig meets primary endpoint in pivotal BRUNELLO trial for diabetic macular edemaMerck reported topline results from the pivotal Phase 2b/3 BRUNELLO trial of remigromig in adults with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL8XG8bK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU0868494708.USD","BK4533","PPH","BK4007","RXL","LU2023250504.SGD","LU2468319806.SGD","SG9999015358.SGD","IE00B1BXHZ80.USD","LU0472753341.HKD","LU1032466523.USD","LU1066053197.SGD","LU1116320737.USD","LU0124676726.USD","LU1066051811.HKD","LU2491049909.HKD","LU0320765646.SGD","TRUH","LU0203347892.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU1929549753.HKD","LU2361044949.HKD","LU1934455194.USD","LU0057025933.USD","LU0106261372.USD","LU2125909593.SGD","BK4585","IE0009355771.USD","IE00BLSP4452.SGD","LU1430594728.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","BK4550","LU1023059063.AUD","LU1061106388.HKD","LU2433249047.HKD","SG9999013999.USD","LU0130517989.USD","LU0069063385.USD","LU2491050154.USD","LU0965508806.USD","LU1585245621.USD","LU1941712264.USD","LU0965509010.AUD","LU0234572021.USD","LU0203345920.USD","LU0058720904.USD","LU0122379950.USD","LU1035773651.USD","LU0689626769.HKD","LU0208291251.USD","BK4534","SG9999002224.SGD","LU0320765489.SGD","SG9999014559.SGD","SG9999014575.USD","LU2112291526.USD","LU0289739699.SGD","LU0162691827.USD","LU1162221912.USD","IXJ","VHT","LU0823416689.USD","LU1093756168.USD","LU2357627491.SGD","LU0965509101.SGD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","LU0648001328.SGD","SG9999014542.SGD","PAWZ","LU1934455277.USD","LU1989772923.USD","LU0511384066.AUD","GDOC","BMED","LU0985320562.USD","MRK","LU0070302665.USD","LU2360032135.SGD","LU1069347547.HKD","LU0861579265.USD","LU2106854487.HKD","LU0072461881.USD","SG9999015341.SGD","LU1974910355.USD","IYH","BK4588","LU1923622614.USD","LU1037948541.HKD","LU0211331839.USD","SG9999002232.USD","LU1934455863.HKD","LU1201861249.SGD","LU2361044865.SGD","SG9999001176.USD","SG9999001440.SGD","XLV","LU0289961442.SGD","LU2324357040.USD","LU0006306889.USD","LU0265550359.USD","LU0868494617.USD","IHE","LU0980610538.SGD","LU1291159041.SGD","LU0942090050.USD","IE00BBT3K403.USD","LU2023250843.SGD","LU1699723380.USD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","HRTS","IE00B2B36J28.USD","LU1571399168.USD","LU1066051225.USD","LU0965509283.SGD","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1983299246.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU1116320901.HKD","LU0266013472.USD","LU0477156953.USD","LU1917777945.USD","SG9999001176.SGD","LU1037948897.HKD","FHLC","LU2125154778.USD","LU2361045086.USD","JDOC","LU2125154935.USD","LU0130102774.USD","LU0859254822.USD","BK4516","LU0289739343.SGD","LU2491050071.SGD","SG9999014567.USD","FTXH","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464259","title":"Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464259?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:45","pubTimestamp":1790246700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA2Q9NDG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","IE0001KFT4U8.USD","LU1917777945.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464254","title":"U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464254?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:45","pubTimestamp":1790246700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA2Q9NDG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0385154629.USD","LU0820561909.HKD","SGXZ99366536.SGD","LU0210536198.USD","LU0320765992.SGD","IXJ","IE00BK4W5L77.USD","LU0061475181.USD","LU0225283273.USD","LU2106854487.HKD","LU2471134796.USD","GDOC","LU1804176565.USD","BK4007","LU0097036916.USD","SG9999014898.SGD","TRUH","LU0882574055.USD","LU2237443622.USD","LU1868836914.USD","LLYZ","IE0004445239.USD","LU1093756325.SGD","IE00BFSS8Q28.SGD","LU1814569148.SGD","LU2213496289.HKD","LU2237443978.SGD","LU2471134879.HKD","LU2491050154.USD","VHT","LU0943347566.SGD","IYH","LU0640476718.USD","LU2552382058.USD","IE00B4JS1V06.HKD","LU0079474960.USD","LU1267930730.SGD","LU2264538146.SGD","LU1691799644.USD","FHLC","LU1127390331.HKD","LU0432979614.USD","LU0006306889.USD","SGXZ81514606.USD","LU1551013342.USD","LU0198837287.USD","XLV","SG9999018865.SGD","LU0316494557.USD","LU1064131342.USD","LU1623119135.USD","LU1868836591.USD","SG9999015986.USD","LU0256863902.USD","SG9999001176.SGD","LU2602419157.SGD","LU2237438978.USD","LU1551013425.SGD","IE00BKDWB100.SGD","LU1868837300.USD","MEDX","IE0002141913.USD","IHE","WDNA","LU2111349929.HKD","IE00BK4W5M84.HKD","LU0345770308.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","BK4599","LU0106261372.USD","LU2063271972.USD","LU2168564495.EUR","LU0109391861.USD","FTXH","LU1720051108.HKD","LU0787776722.HKD","LU0820561818.USD","LU1323610961.USD","LU0109394709.USD","LU1979441026.SGD","LU2023251221.USD","LU2750360997.AUD","LU0174119429.USD","IE00B2B36J28.USD","LU0708995401.HKD","CURE","LU2750360641.GBP","LU1868836757.USD","LU1057294990.SGD","OZEM","LU1232071149.USD","LU2360106947.USD","BK4581","LU0882574139.USD","LU0672654240.SGD","LU1629891620.HKD","BK4534","BK4585","LU0683600562.USD","LU2168564065.EUR","IE00B7KXQ091.USD","GB00BDT5M118.USD","LU0266013472.USD","IE00BWXC8680.SGD","LU2361044865.SGD","LU0786609619.USD","LU2271345857.HKD","LU2552382215.SGD","IE0001KFT4U8.USD","LU2108987350.USD","SG9999013999.USD","SG9999017495.SGD","LU1988902786.USD","CANC","LU2087625088.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823434583.USD","BK4516","LU2746668461.USD","LU2112291526.USD","LU1280957306.USD","LU0238689110.USD","LU0114720955.EUR","LU2361045086.USD","LLY","LU2491049909.HKD","LU2462591350.SGD","LU2211815571.USD","LU0823416689.USD","IE0005OL40V9.USD","LU0354030438.USD","LU1720051017.SGD","THNR","LU2756315318.SGD","LU2461242641.AUD","LU1974910355.USD","IE00BKPKM429.USD","LU1035775433.USD","LU1983299246.USD","SG9999015978.USD","ELIL","LU0689472784.USD","LU1145028129.USD","LU2237443465.HKD","SG9999001176.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU0096364046.USD","IE00BJLML261.HKD","LU2456880835.USD","LU2468319806.SGD","SG9999018857.SGD","LU0823434740.USD","LU2417539215.USD","LU2023250504.SGD","SG9999014880.SGD","SG9999015952.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1093756168.USD","BK4588","LU2896262040.SGD","IE0004445015.USD","PJP","LU1291159041.SGD","LU1366192091.USD","LU2168563687.JPY","ILDR","LU0289739699.SGD","SG9999014914.USD","LU0323591593.USD","LU0234572021.USD","LLII","HRTS","LU2746668974.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","IE00BFSS7M15.SGD","LU0353189763.USD","SG9999014906.USD","LU0353189680.USD","LU1023059063.AUD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU2028103732.USD","IE00BJJMRY28.SGD","LU0345770993.USD","LU0889565916.HKD","LU2237443382.USD","LU0471298777.SGD","LU1712237335.SGD","BK4533","LU2756315664.SGD","LU2236285917.USD","AGNG","LU2265009873.SGD","LU2462157665.USD","PPH","JDOC","IE00B775H168.HKD","SG9999015945.SGD","IE00BJJMRX11.SGD","LU1069344957.HKD","IE00BN29S564.USD","LLYX","LU2237443549.SGD","LU2168564149.EUR","LU1868837136.USD","LU2089284900.SGD","LU2491050071.SGD","LU0158827948.USD","LU0256863811.USD","LU2089984988.USD","LU2237443895.HKD","LU0158827781.USD","LU2023250330.USD","LU0466842654.USD","LU0471298694.HKD","LU0354030511.USD","ELIS","LU2168564222.USD","RXL","LU0133085943.USD","MEDI","LU0820562030.AUD","LU0320765059.SGD","LU0203201768.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","MHIP","LU1548497426.USD","LU2361044949.HKD","LU0964807845.USD","TMED","LU0122379950.USD","LU0203202063.USD","LU1061106388.HKD","LU1917777945.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU2471134523.USD","IE0009355771.USD","LU0094547139.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":12,"totalSize":295,"code":"91000000","status":"200"}]}}